Curaleaf Holdings (CURLF) Cash from Discontinued Operations (2022 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Cash from Discontinued Operations of 2435000.0 in Q4 2024, down 2559.6% quarter-over-quarter from 99000.0 in Q3 2024, and down 100.58% on a YoY basis from 422298571.43 in Q1 2024.
Curaleaf Holdings (CURLF) Cash from Discontinued Operations (2022 - 2024) Analysis & Trends
Curaleaf Holdings' Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 2435000.0 for Q4 2024.
- In Q4 2024, Cash from Discontinued Operations fell 100.58% year-over-year to 2435000.0; the TTM figure through Dec 2024 stood at 5503000.0 (up 65.57% YoY), while the FY2025 annual figure was 14319000.0, down 160.2% from the prior year.
- Cash from Discontinued Operations was 2435000.0 for Q4 2024 at Curaleaf Holdings, down from 99000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 9820868000.0 in Q2 2023 to a low of 9846000000.0 in Q1 2023.
- Historically, Cash from Discontinued Operations has averaged 3019800.0 across 3 years, with a median of 557500.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Cash from Discontinued Operations surged 1141.08% in 2023, then slumped 176.97% in 2024.
- A 3-year view of Cash from Discontinued Operations shows it stood at 9547000.0 in 2022, then surged by 87.28% to 1214000.0 in 2023, then tumbled by 100.58% to 2435000.0 in 2024.
- The last three Cash from Discontinued Operations figures came in at 2435000.0 (Q4 2024), 99000.0 (Q3 2024), and 7559167000.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.44 Mn |
| Dec 31, 2024 | -2.44 Mn |
| Sep 30, 2024 | 99,000.00 |
| Sep 30, 2024 | 99,000.00 |
| Jun 30, 2024 | -7.56 Bn |
| Jun 30, 2024 | -7.56 Bn |
| Mar 31, 2024 | 7.56 Bn |
| Mar 31, 2024 | 7.56 Bn |
| Dec 31, 2023 | -1.21 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Sep 30, 2023 | 10.36 Mn |
| Sep 30, 2023 | 10.36 Mn |
| Jun 30, 2023 | 9.82 Bn |
| Jun 30, 2023 | 9.82 Bn |
| Mar 31, 2023 | -9.85 Bn |
| Mar 31, 2023 | -9.85 Bn |
| Dec 31, 2022 | -9.55 Mn |
| Dec 31, 2022 | -9.55 Mn |
| Sep 30, 2022 | 835,000.00 |
| Sep 30, 2022 | 835,000.00 |